News
1d
Verywell Health on MSNNot Enough Adults Are Getting the RSV Vaccine. Here's Why That MattersFact checked by Nick Blackmer The Centers for Disease Control and Prevention (CDC) has expanded the RSV vaccine ...
The Trump administration appears to be expanding RSV vaccinations to some adults starting at age 50, down from 60, following ...
Respiratory syncytial virus is common but it can be dangerous for some infants and young kids. Here's everything parents need ...
Cases of RSV across the country are considered "very high," as rates of other acute respiratory illnesses are also high, the CDC reported Monday.
The eight new ACIP members met for the first time June 25 after Kennedy fired all 17 original members of the committee June 9 ...
5d
HealthDay on MSNCDC Now Recommends RSV Vaccine for Some Adults Aged 50 Years and OlderThe CDC already recommends the RSV shot for all adults 75 and older and for people 60 and older who have health conditions that increase their risk of severe RSV. It also recommends the shot during ...
The CDC recommends all adults ages 75 and older and for adults ages 60 to 74 who are at increased risk of severe RSV disease to get a single dose of the RSV vaccine.
1d
AllAfrica on MSNGovernment Is Considering Providing a Vaccine to Protect Babies From RSVA new respiratory syncytial virus vaccine to protect infants from severe illness is available in South Africa's private sector but not yet in public clinics. The country's advisory group on ...
6d
Health and Me on MSNThere’s Urgent Need For RSV Immunisation In India As Virus Continuous To Claim Infant Lives, Says Top PediatricianRSV is causing thousands of infant deaths in India yearly, yet remains underdiagnosed. Experts stress the urgent need for ...
According to the CDC, RSV symptoms make it difficult to distinguish it from the common cold or other respiratory viruses like the flu or COVID-19.
Understanding the differences between colds, flu, and RSV can help in identifying the illness you're dealing with, the ...
A CDC advisory panel on Thursday voted 5-2 to recommend the use of a new preventative RSV therapy in babies, Merck’s Enflonsia.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results